{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T03:09:29Z","timestamp":1792724969446,"version":"4.5.0"},"reference-count":60,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Bioorganic Chemistry"],"published-print":{"date-parts":[[2026,7]]},"DOI":"10.1016\/j.bioorg.2026.109778","type":"journal-article","created":{"date-parts":[[2026,3,20]],"date-time":"2026-03-20T00:47:17Z","timestamp":1773967637000},"page":"109778","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":17,"special_numbering":"C","title":["Targeting cholinergic dysfunction and neuroinflammation through rationally designed Thieno[3,2-d]pyrimidine hybrids"],"prefix":"10.1016","volume":"175","author":[{"given":"Feyzi Sinan","family":"Tokal\u0131","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ozden Ozgun","family":"Acar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yeliz","family":"Demir","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Halil","family":"\u015eenol","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Busra","family":"Acar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Furkan","family":"\u00c7ak\u0131r","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alaattin","family":"Sen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"3","key":"10.1016\/j.bioorg.2026.109778_bb0005","doi-asserted-by":"crossref","first-page":"1851","DOI":"10.3390\/ijms23031851","article-title":"A review of the common neurodegenerative disorders: current therapeutic approaches and the potential role of nanotherapeutics","volume":"23","author":"Lamptey","year":"2022","journal-title":"Int. J. Mol. Sci."},{"issue":"6","key":"10.1016\/j.bioorg.2026.109778_bb0010","doi-asserted-by":"crossref","first-page":"1816","DOI":"10.3390\/molecules27061816","article-title":"Role of cholinergic Signaling in Alzheimer\u2019s disease","volume":"27","author":"Chen","year":"2022","journal-title":"Molecules"},{"issue":"1","key":"10.1016\/j.bioorg.2026.109778_bb0015","doi-asserted-by":"crossref","DOI":"10.5493\/wjem.v14.i1.87202","article-title":"Emerging significance of butyrylcholinesterase","volume":"14","author":"Sridhar","year":"2024","journal-title":"world J. Exp. Med."},{"key":"10.1016\/j.bioorg.2026.109778_bb0020","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2021.113320","article-title":"Alzheimer\u2019s disease and its treatment by different approaches: a review","volume":"216","author":"Srivastava","year":"2021","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.bioorg.2026.109778_bb0025","article-title":"Natural acetylcholinesterase inhibitors: a multi-targeted therapeutic potential in Alzheimer\u2019s disease","volume":"11","author":"Gajendra","year":"2024","journal-title":"Eur. J. Med. Chem. Rep."},{"issue":"2","key":"10.1016\/j.bioorg.2026.109778_bb0030","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1097\/WCO.0000000000000911","article-title":"The role of innate immune genes in Alzheimer\u2019s disease","volume":"34","author":"Gricuic","year":"2021","journal-title":"Curr. Opin. Neurol."},{"issue":"11","key":"10.1016\/j.bioorg.2026.109778_bb0035","doi-asserted-by":"crossref","first-page":"2776","DOI":"10.1093\/brain\/awx154","article-title":"Cell-based therapeutic strategies for multiple sclerosis","volume":"140","author":"Scolding","year":"2017","journal-title":"Brain"},{"key":"10.1016\/j.bioorg.2026.109778_bb0040","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1016\/j.neuroscience.2014.09.061","article-title":"Neuroinflammation in Alzheimer\u2019s disease; a source of heterogeneity and target for personalized therapy","volume":"302","author":"Latta","year":"2015","journal-title":"Neuroscience"},{"key":"10.1016\/j.bioorg.2026.109778_bb0045","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1038\/s41577-022-00684-6","article-title":"Inflammation and immune dysfunction in Parkinson disease","volume":"22","author":"Tansey","year":"2022","journal-title":"Nat. Rev. Immunol."},{"issue":"3","key":"10.1016\/j.bioorg.2026.109778_bb0050","doi-asserted-by":"crossref","DOI":"10.1016\/j.neurot.2025.e00540","article-title":"Astrocyte and oligodendrocyte pathology in Alzheimer\u2019s disease","volume":"22","author":"Ziar","year":"2025","journal-title":"Neurotherapeutics"},{"key":"10.1016\/j.bioorg.2026.109778_bb0055","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1007\/s10787-023-01192-2","article-title":"A story of the potential effect of non-steroidal anti-inflammatory drugs (NSAIDs) in Parkinson\u2019s disease: beneficial or detrimental effects","volume":"31","author":"Alrouji","year":"2023","journal-title":"Inflammopharmacol"},{"key":"10.1016\/j.bioorg.2026.109778_bb0060","doi-asserted-by":"crossref","first-page":"3261","DOI":"10.1038\/s41467-018-05800-6","article-title":"Resolution of chronic inflammatory disease: universal and tissue-specific concepts","volume":"9","author":"Schett","year":"2018","journal-title":"Nat. Commun."},{"issue":"41","key":"10.1016\/j.bioorg.2026.109778_bb0065","article-title":"Interaction of Inula viscosa (L.) Aiton with Iba1 via Rosmarinic acid and rutin: insights from computational models and biological effects","volume":"10","author":"Pepe","year":"2025","journal-title":"ChemistrySelect"},{"issue":"9","key":"10.1016\/j.bioorg.2026.109778_bb0070","doi-asserted-by":"crossref","DOI":"10.1002\/ardp.70081","article-title":"Synthesis, characterization, and comprehensive in vitro and in silico evaluation of the anti-inflammatory potential of novel 1,2,3-triazole\u2013Arylidenehydrazide\/Thiazolidinone hybrids","volume":"358","author":"Pepe","year":"2025","journal-title":"Arch. Pharm."},{"key":"10.1016\/j.bioorg.2026.109778_bb0075","doi-asserted-by":"crossref","DOI":"10.1016\/j.bioorg.2025.108869","article-title":"Novel thiazolidinedione hybrids as cholinesterase inhibitors and targeting neuroblastoma: design, synthesis, in vitro and in silico biological evaluations","volume":"164","author":"Turgut","year":"2025","journal-title":"Bioorg. Chem."},{"key":"10.1016\/j.bioorg.2026.109778_bb0080","doi-asserted-by":"crossref","DOI":"10.1016\/j.abb.2025.110450","article-title":"Design, synthesis, and biological studies of isoniazid-based hydrazone derivatives: antibacterial, anticancer, and enzyme inhibitory properties","volume":"770","author":"Kalay","year":"2025","journal-title":"Arch. Biochem. Biophys."},{"key":"10.1016\/j.bioorg.2026.109778_bb0085","doi-asserted-by":"crossref","DOI":"10.1016\/j.compbiolchem.2025.108683","article-title":"Morpholine-modified thiosemicarbazones and thiazolidin-4-ones against Alzheimer\u2019s key enzymes: from synthesis to inhibition","volume":"120","author":"Demir","year":"2026","journal-title":"Comput. Biol. Chem."},{"key":"10.1016\/j.bioorg.2026.109778_bb0090","doi-asserted-by":"crossref","first-page":"50186","DOI":"10.1039\/D5RA07416A","article-title":"New Mannich-type arylidenerhodanines as potent inhibitors of AChE and BChE: synthesis, biological evaluation, cytotoxicity and molecular modeling","volume":"15","author":"Tokal\u0131","year":"2025","journal-title":"RSC Adv."},{"issue":"1","key":"10.1016\/j.bioorg.2026.109778_bb0095","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1080\/14756366.2016.1243534","article-title":"Tertiary amine derivatives of chlorochalcone as acetylcholinesterase (AChE) and buthylcholinesterase (BuChE) inhibitors: the influence of chlorine, alkyl amine side chain and \u03b1,\u03b2-unsaturated ketone group","volume":"32","author":"Gao","year":"2017","journal-title":"J. Enzyme Inhib. Med. Chem."},{"key":"10.1016\/j.bioorg.2026.109778_bb0100","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2022.114248","article-title":"From tryptophan-based amides to tertiary amines: optimization of a butyrylcholinesterase inhibitor series","volume":"234","author":"Meden","year":"2022","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.bioorg.2026.109778_bb0105","doi-asserted-by":"crossref","first-page":"35","DOI":"10.3390\/ph15010035","article-title":"Thienopyrimidine: a promising scaffold to access anti-infective agents","volume":"15","author":"Lagardere","year":"2022","journal-title":"Pharmaceuticals"},{"issue":"9","key":"10.1016\/j.bioorg.2026.109778_bb0110","doi-asserted-by":"crossref","first-page":"1910","DOI":"10.1016\/j.bmcl.2015.03.031","article-title":"2-(Isopropylamino)thieno[3,2-d]pyrimidin-4(3H)-one derivatives as selective phosphodiesterase 7 inhibitors with potent in vivo efficacy","volume":"25","author":"Endo","year":"2015","journal-title":"Bioorg. Med. Chem. Lett."},{"issue":"23","key":"10.1016\/j.bioorg.2026.109778_bb0115","doi-asserted-by":"crossref","first-page":"9844","DOI":"10.1021\/jm5008215","article-title":"Discovery of 2-(Cyclopentylamino)thieno[3,2-d]pyrimidin-4(3H)-one derivatives as a new series of potent phosphodiesterase 7 inhibitors","volume":"57","author":"Kawai","year":"2014","journal-title":"J. Med. Chem."},{"issue":"3","key":"10.1016\/j.bioorg.2026.109778_bb0120","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1016\/j.bmcl.2014.11.090","article-title":"Discovery and SAR study of 2-(4-pyridylamino)thieno[3,2-d]pyrimidin-4(3H)-ones as soluble and highly potent PDE7 inhibitors","volume":"25","author":"Endo","year":"2015","journal-title":"Bioorg. Med. Chem. Lett."},{"key":"10.1016\/j.bioorg.2026.109778_bb0125","doi-asserted-by":"crossref","first-page":"28","DOI":"10.3390\/scipharm86030028","article-title":"Anticancer activity evaluation of new Thieno[2,3-d]pyrimidin-4(3H)-ones and Thieno[3,2-d]pyrimidin-4(3H)-one derivatives","volume":"86","author":"Shyyka","year":"2018","journal-title":"Sci. Pharm."},{"key":"10.1016\/j.bioorg.2026.109778_bb0130","doi-asserted-by":"crossref","first-page":"743","DOI":"10.1016\/j.ejmech.2014.10.076","article-title":"Mannich bases in medicinal chemistry and drug design","volume":"89","author":"Roman","year":"2015","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.bioorg.2026.109778_bb0135","doi-asserted-by":"crossref","DOI":"10.1016\/j.molstruc.2025.144425","article-title":"Design and synthesis of new thienopyrimidine derivatives as potential anticancer agents: from cytotoxicity screening to VEGFR inhibition modeling","volume":"1352","author":"Tokal\u0131","year":"2026","journal-title":"J. Mol. Struct."},{"key":"10.1016\/j.bioorg.2026.109778_bb0140","doi-asserted-by":"crossref","DOI":"10.1016\/j.bmc.2025.118264","article-title":"Development of phenolic Mannich bases as \u03b1-glucosidase and aldose reductase inhibitors: in vitro and in silico approaches for managing diabetes mellitus and its complications","volume":"128","author":"Tokal\u0131","year":"2025","journal-title":"Bioorg. Med. Chem."},{"key":"10.1016\/j.bioorg.2026.109778_bb0145","doi-asserted-by":"crossref","DOI":"10.1016\/j.bioorg.2025.108614","article-title":"Design, synthesis, and aldose reductase inhibition assessment of novel Quinazolin-4(3H)-one derivatives with 4-Bromo-2-fluorobenzene functionality","volume":"162","author":"Tokal\u0131","year":"2025","journal-title":"Bioorg. Chem."},{"issue":"14","key":"10.1016\/j.bioorg.2026.109778_bb0150","doi-asserted-by":"crossref","first-page":"2975","DOI":"10.3390\/molecules30142975","article-title":"Dual inhibitors of acetylcholinesterase and monoamine oxidase-B for the treatment of Alzheimer\u2019s disease","volume":"30","author":"Asim","year":"2025","journal-title":"Molecules"},{"key":"10.1016\/j.bioorg.2026.109778_bb0155","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2022.114510","article-title":"A highly effective and stable butyrylcholinesterase inhibitor with multi-faceted neuroprotection and cognition improvement","volume":"239","author":"Li","year":"2022","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.bioorg.2026.109778_bb0160","doi-asserted-by":"crossref","DOI":"10.1016\/j.bioorg.2021.105149","article-title":"Pharmacophore-based drug design of AChE and BChE dual inhibitors as potential anti-Alzheimer\u2019s disease agents","volume":"114","author":"Gao","year":"2021","journal-title":"Bioorg. Chem."},{"issue":"2","key":"10.1016\/j.bioorg.2026.109778_bb0165","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1038\/nrd.2017.219","article-title":"Mechanistic enzymology in drug discovery: a fresh perspective","volume":"17","author":"Holdgate","year":"2018","journal-title":"Nat. Rev. Drug Discov."},{"issue":"9","key":"10.1016\/j.bioorg.2026.109778_bb0170","doi-asserted-by":"crossref","first-page":"322","DOI":"10.3390\/bios11090322","article-title":"The kinetic and analytical aspects of enzyme competitive inhibition: sensing of tyrosinase inhibitors","volume":"11","author":"Attaallah","year":"2021","journal-title":"Biosensors"},{"issue":"1","key":"10.1016\/j.bioorg.2026.109778_bb0175","doi-asserted-by":"crossref","first-page":"71","DOI":"10.3390\/biomedicines14010071","article-title":"Stability of myeloid cell phenotype and function across a broad age range in humans and Cynomolgus monkeys, and a dominant contribution of humoral factors in the control of bacterial infection","volume":"14","author":"Lysakova","year":"2026","journal-title":"Biomedicines"},{"key":"10.1016\/j.bioorg.2026.109778_bb0180","series-title":"Pathology issues in the Design of Toxicology Studies, Handbook of Toxicologic Pathology (Second Edition)","first-page":"307","volume":"1","author":"Ochoa","year":"2002"},{"issue":"11","key":"10.1016\/j.bioorg.2026.109778_bb0185","doi-asserted-by":"crossref","first-page":"1763","DOI":"10.1089\/ars.2009.3074","article-title":"Cellular stress responses, the hormesis paradigm, and Vitagenes: novel targets for therapeutic intervention in neurodegenerative disorders","volume":"13","author":"Calabrese","year":"2010","journal-title":"Antioxid. Redox Signal."},{"key":"10.1016\/j.bioorg.2026.109778_bb0190","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.bbi.2016.07.146","article-title":"Involvement of the IL-1 system in experimental autoimmune encephalomyelitis and multiple sclerosis: breaking the vicious cycle between IL-1\u03b2 and GM-CSF","volume":"62","author":"Par\u00e9","year":"2017","journal-title":"Brain Behav. Immun."},{"key":"10.1016\/j.bioorg.2026.109778_bb0195","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1007\/s12640-020-00270-5","article-title":"Sepsis and cerebral dysfunction: BBB damage, neuroinflammation, oxidative stress, apoptosis and autophagy as key mediators and the potential therapeutic approaches","volume":"39","author":"Gu","year":"2021","journal-title":"Neurotox. Res."},{"issue":"16","key":"10.1016\/j.bioorg.2026.109778_bb0200","doi-asserted-by":"crossref","first-page":"8972","DOI":"10.3390\/ijms23168972","article-title":"The pivotal role of NF-kB in the pathogenesis and therapeutics of Alzheimer\u2019s disease","volume":"23","author":"Sun","year":"2022","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.bioorg.2026.109778_bb0205","doi-asserted-by":"crossref","DOI":"10.1007\/s44466-025-00014-0","article-title":"NF-\u03baB: master regulator of cellular responses in health and disease","volume":"1","author":"Hoffmann","year":"2025","journal-title":"Immun. Inflamm."},{"issue":"1","key":"10.1016\/j.bioorg.2026.109778_bb0210","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1152\/physrev.00029.2006","article-title":"Nitric oxide and Peroxynitrite in health and disease","volume":"87","author":"Pacher","year":"2007","journal-title":"Physiol. Rev."},{"issue":"5","key":"10.1016\/j.bioorg.2026.109778_bb0215","doi-asserted-by":"crossref","first-page":"1195","DOI":"10.3390\/cells10051195","article-title":"Neuroinflammation: integrated nervous tissue response through intercellular interactions at the \u201cwhole system\u201d scale","volume":"10","author":"Nosi","year":"2021","journal-title":"Cells"},{"issue":"2","key":"10.1016\/j.bioorg.2026.109778_bb0220","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1006\/bbrc.2001.5388","article-title":"Iba1 is an actin-cross-linking protein in macrophages\/microglia","volume":"286","author":"Sasaki","year":"2001","journal-title":"Biochem. Biophys. Res. Commun."},{"issue":"17","key":"10.1016\/j.bioorg.2026.109778_bb0225","doi-asserted-by":"crossref","first-page":"2939","DOI":"10.1055\/a-2541-1072","article-title":"Synthesis, characterization and in vitro and in silico biological evaluation of new Mannich-based Rhodanine and Thiazolidine-2,4-dione derivatives as potential anti-lung-Cancer agents","volume":"36","author":"Ate\u015fo\u011flu","year":"2025","journal-title":"Synlett"},{"issue":"10","key":"10.1016\/j.bioorg.2026.109778_bb0230","doi-asserted-by":"crossref","DOI":"10.1002\/slct.202205039","article-title":"New Diacetic acids containing Quinazolin-4(3H)-one: synthesis, characterization, anticholinergic properties, DFT analysis and molecular docking studies","volume":"8","author":"Tokal\u0131","year":"2023","journal-title":"ChemistrySelect"},{"key":"10.1016\/j.bioorg.2026.109778_bb0235","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1016\/0006-2952(61)90145-9","article-title":"A new and rapid colorimetric determination of acetylcholinesterase activity","volume":"7","author":"Ellman","year":"1961","journal-title":"Biochem. Pharmacol."},{"issue":"3","key":"10.1016\/j.bioorg.2026.109778_bb0240","doi-asserted-by":"crossref","first-page":"658","DOI":"10.1021\/ja01318a036","article-title":"The determination of enzyme dissociation constants","volume":"56","author":"Lineweaver","year":"1934","journal-title":"J. Am. Chem. Soc."},{"issue":"8","key":"10.1016\/j.bioorg.2026.109778_bb0245","doi-asserted-by":"crossref","DOI":"10.1002\/jbt.70412","article-title":"New Quinazolin-4(3H)-one\u2013Thiazolidine-2,4-Dione hybrids as dual inhibitors of \u03b1-glycosidase and aldose reductase: the synthetic, in vitro, and in silico approaches","volume":"39","author":"Tokal\u0131","year":"2025","journal-title":"J. Biochem. Mol. Toxicol."},{"issue":"2","key":"10.1016\/j.bioorg.2026.109778_bb0250","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1016\/j.bmc.2016.11.015","article-title":"Computer design, synthesis, and bioactivity analyses of drugs like fingolimod used in the treatment of multiple sclerosis","volume":"25","author":"Turgut","year":"2017","journal-title":"Bioorg. Med. Chem."},{"key":"10.1016\/j.bioorg.2026.109778_bb0255","doi-asserted-by":"crossref","DOI":"10.1016\/j.molstruc.2024.139193","article-title":"Amelioration potential of synthetic oxime chemical cores against multiple sclerosis and Alzheimer\u2019s diseases: evaluation in aspects of in silico and in vitro experiments","volume":"1318","author":"Yilmaz","year":"2024","journal-title":"J. Mol. Struct."},{"key":"10.1016\/j.bioorg.2026.109778_bb0260","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1016\/j.jneuroim.2016.07.010","article-title":"Capparis ovata treatment suppresses inflammatory cytokine expression and ameliorates experimental allergic encephalomyelitis model of multiple sclerosis in C57BL\/6 mice","volume":"298","author":"Ozgun-Acar","year":"2016","journal-title":"J. Neuroimmunol."},{"issue":"1","key":"10.1016\/j.bioorg.2026.109778_bb0265","doi-asserted-by":"crossref","first-page":"925","DOI":"10.1080\/13880209.2020.1814356","article-title":"Triterpenoids and steroids isolated from Anatolian Capparis ovata and their activity on the expression of inflammatory cytokines","volume":"58","author":"Gazioglu","year":"2020","journal-title":"Pharm. Biol."},{"key":"10.1016\/j.bioorg.2026.109778_bb0270","article-title":"Neuroinflammatory human brain organoids enable comprehensive drug screening studies: fingolimod and its analogues in focus","volume":"24","author":"Acar","year":"2026","journal-title":"Curr. Med. Chem."},{"key":"10.1016\/j.bioorg.2026.109778_bb0275","doi-asserted-by":"crossref","DOI":"10.1016\/j.molliq.2024.125006","article-title":"New tetrahydro-isoquinoline derivatives as cholinesterase and \u03b1-glycosidase inhibitors: synthesis, characterization, molecular docking & dynamics, ADME prediction, in vitro cytotoxicity and enzyme inhibition studies","volume":"404","author":"Mamedov","year":"2024","journal-title":"J. Mol. Liq."},{"key":"10.1016\/j.bioorg.2026.109778_bb0280","doi-asserted-by":"crossref","DOI":"10.1016\/j.bioorg.2022.105822","article-title":"Quinazolinone-based benzenesulfonamides with low toxicity and high affinity as monoamine oxidase-a inhibitors: synthesis, biological evaluation and induced-fit docking studies","volume":"124","author":"Yamali","year":"2022","journal-title":"Bioorg. Chem."},{"key":"10.1016\/j.bioorg.2026.109778_bb0285","doi-asserted-by":"crossref","DOI":"10.1016\/j.compbiomed.2022.106288","article-title":"Exploring new catechin derivatives as SARS-CoV-2 Mpro inhibitors from tea by molecular networking, surface plasma resonance, enzyme inhibition, induced fit docking, and metadynamics simulations","volume":"151","author":"Yang","year":"2022","journal-title":"Comput. Biol. Med."},{"key":"10.1016\/j.bioorg.2026.109778_bb0290","doi-asserted-by":"crossref","DOI":"10.1016\/j.bioorg.2025.109419","article-title":"Harnessing nature\u2019s building blocks: potent and safe urease inhibition by simple amino acids","volume":"169","author":"Ba\u011f","year":"2026","journal-title":"Bioorg. Chem."},{"key":"10.1016\/j.bioorg.2026.109778_bb0295","doi-asserted-by":"crossref","DOI":"10.1016\/j.molstruc.2024.140153","article-title":"Synthesis, cytotoxic evaluation, and in silico studies of novel benzenesulfonamide-thiazolidinone derivatives against colorectal carcinoma","volume":"1321","author":"Zengin-Kurt","year":"2025","journal-title":"J. Mol. Struct."},{"key":"10.1016\/j.bioorg.2026.109778_bb0300","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2025.117915","article-title":"Synthesis, characterization, in vitro and in silico investigations of novel 1,2,3-triazole substituted salicylic acid phenolic hydrazones hybrids targeting TGF-\u03b22 expression in colorectal carcinoma","volume":"296","author":"Ay","year":"2025","journal-title":"Eur. J. Med. Chem."}],"container-title":["Bioorganic Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0045206826003147?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0045206826003147?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,4,11]],"date-time":"2026-04-11T13:24:48Z","timestamp":1775913888000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0045206826003147"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7]]},"references-count":60,"alternative-id":["S0045206826003147"],"URL":"https:\/\/doi.org\/10.1016\/j.bioorg.2026.109778","relation":{},"ISSN":["0045-2068"],"issn-type":[{"value":"0045-2068","type":"print"}],"subject":[],"published":{"date-parts":[[2026,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Targeting cholinergic dysfunction and neuroinflammation through rationally designed Thieno[3,2-d]pyrimidine hybrids","name":"articletitle","label":"Article Title"},{"value":"Bioorganic Chemistry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bioorg.2026.109778","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"109778"}}